Camptothecin-based chemotherapy combined with monoclonal antibody therapy targeting GD2 or VEGF

Research studies on Camptothecin-based chemotherapy combined with monoclonal antibody therapy targeting GD2 or VEGF - conditions it treats, mechanisms of action, and clinical outcomes from peer-reviewed literature.